Quarry LP Purchases 1,501 Shares of Danaher Corporation $DHR

Key Points

• Quarry LP significantly increased its holdings in Danaher Corporation by 3,848.7% in Q1, owning 1,540 shares valued at approximately $316,000.
• During the same quarter, several institutional investors made notable trades, including Baird Financial Group boosting their stake by 290.6% to over 1.4 million shares.
• Danaher reported Q2 earnings of $1.80 per share, surpassing analysts' estimates, and had a revenue of $5.94 billion, representing a 3.4% year-over-year increase.

Quarry LP raised its position in Danaher Corporation (NYSE:DHR - Free Report) by 3,848.7% during the first quarter, according to the company in its most recent disclosure with the SEC. The firm owned 1,540 shares of the conglomerate's stock after acquiring an additional 1,501 shares during the quarter. Quarry LP's holdings in Danaher were worth $316,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also bought and sold shares of the stock. Coastal Bridge Advisors LLC increased its position in Danaher by 4.8% in the fourth quarter. Coastal Bridge Advisors LLC now owns 1,099 shares of the conglomerate's stock worth $252,000 after buying an additional 50 shares in the last quarter. Hills Bank & Trust Co increased its position in Danaher by 0.3% in the first quarter. Hills Bank & Trust Co now owns 18,015 shares of the conglomerate's stock worth $3,693,000 after buying an additional 53 shares in the last quarter. Sageworth Trust Co increased its position in Danaher by 2.3% in the first quarter. Sageworth Trust Co now owns 2,404 shares of the conglomerate's stock worth $493,000 after buying an additional 54 shares in the last quarter. 1834 Investment Advisors Co. increased its position in Danaher by 3.3% in the first quarter. 1834 Investment Advisors Co. now owns 1,666 shares of the conglomerate's stock worth $342,000 after buying an additional 54 shares in the last quarter. Finally, Rakuten Securities Inc. increased its position in Danaher by 33.3% in the first quarter. Rakuten Securities Inc. now owns 224 shares of the conglomerate's stock worth $46,000 after buying an additional 56 shares in the last quarter. Hedge funds and other institutional investors own 79.05% of the company's stock.

Insider Buying and Selling

In related news, Director Teri List sold 2,778 shares of the stock in a transaction that occurred on Friday, August 22nd. The stock was sold at an average price of $211.06, for a total transaction of $586,324.68. Following the completion of the transaction, the director directly owned 20,751 shares of the company's stock, valued at approximately $4,379,706.06. This represents a 11.81% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Insiders own 11.20% of the company's stock.

Wall Street Analysts Forecast Growth

A number of brokerages have commented on DHR. Scotiabank upgraded Danaher from a "sector perform" rating to a "sector outperform" rating and set a $275.00 price target for the company in a research report on Friday, July 11th. UBS Group reduced their price target on Danaher from $240.00 to $225.00 and set a "buy" rating for the company in a research report on Wednesday, July 23rd. Evercore ISI reduced their price target on Danaher from $230.00 to $226.00 and set an "outperform" rating for the company in a research report on Tuesday, July 8th. Royal Bank Of Canada set a $241.00 target price on Danaher in a research report on Tuesday. Finally, Robert W. Baird increased their target price on Danaher from $225.00 to $226.00 and gave the stock an "outperform" rating in a research report on Friday, July 18th. Seventeen investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company's stock. Based on data from MarketBeat, the company has an average rating of "Moderate Buy" and a consensus price target of $246.35.

Danaher Price Performance

Shares of NYSE:DHR traded down $4.39 during trading on Wednesday, hitting $199.40. 3,468,205 shares of the company's stock were exchanged, compared to its average volume of 2,972,602. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.62 and a quick ratio of 1.22. Danaher Corporation has a 52-week low of $171.00 and a 52-week high of $279.90. The business's 50-day simple moving average is $201.94 and its 200 day simple moving average is $199.49. The company has a market cap of $142.78 billion, a price-to-earnings ratio of 42.43, a PEG ratio of 2.87 and a beta of 0.75.

Danaher (NYSE:DHR - Get Free Report) last announced its quarterly earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 EPS for the quarter, beating analysts' consensus estimates of $1.64 by $0.16. Danaher had a return on equity of 10.70% and a net margin of 14.21%.The company had revenue of $5.94 billion during the quarter, compared to analyst estimates of $5.83 billion. During the same period in the prior year, the company earned $1.72 earnings per share. The firm's revenue was up 3.4% on a year-over-year basis. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. As a group, equities analysts predict that Danaher Corporation will post 7.63 EPS for the current year.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.